MSAC 1623: ADAR Commentry for LuxturnaTM (voretigene neparvovec) for the treatment of biallelic RPE-65-mediated Inherited Retinal Dystrophies (CHERE)

Project Member(s): Goodall, S., De Abreu Lourenco, R., Vargas Parada, C., Arora, S.

Funding or Partner Organisation: Commonwealth Department of Health and Aged Care (Commonwealth Department of Health and Aged Care: C)
Commonwealth Department of Health and Aged Care (Commonwealth Department of Health and Aged Care: C)

Start year: 2020

FOR Codes: Health economics , Health Economics, Evaluation of Health Outcomes

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.